FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis

by Pill Pals Customer Service | Aug 14, 2025 | News

For Immediate Release: August 14, 2025 Today, the U.S. Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba), a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent...

Fromi USA Recalls Brie Royal Faucon 1kg Because of Possible Health Risk

by Pill Pals Customer Service | Aug 14, 2025 | News

Summary Company Announcement Date: August 14, 2025 FDA Publish Date: August 14, 2025 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential contamination with Listeria monocytogenes Company Name: Fromi USA Brand Name: Product...

Pediatric Anesthesia

by Pill Pals Customer Service | Aug 14, 2025 | News

Millions of children receive anesthesia and sedation drugs each year for surgeries and procedures; however, until recently, little was known about these drugs’ effects on the developing brain. Research studies have found that early exposure in juvenile animals to...

Lessons Learned From the CMC Development and Readiness Pilot Program

by Pill Pals Customer Service | Aug 14, 2025 | News

On This Page Date: September 10, 2025 Time: 1:00 p.m. – 5:00 p.m. ET FDA and the Duke-Margolis Institute for Health Policy will host a virtual workshop on September 10, 2025 that will delve into the challenges and strategies for expedited chemistry,...

The Center for Research on Complex Generics

by Pill Pals Customer Service | Aug 14, 2025 | News

On August 1, 2020 the FDA awarded a five-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG). The center aims to enhance research collaborations with the generic industry to further the...